Flosonics Medical, based in Toronto, was founded on the mission of enhancing patient care through technology that supports clinicians. Specializing in ultrasound technology and critical care medicine, Flosonics has pioneered the development of FloPatch, a wireless, patient-worn Doppler ultrasound. FloPatch equips clinicians with the ability to assess the left ventricle function non-invasively in real-time, which is vital for the management of fluids in patients with critical conditions such as sepsis. Designed for ease of use, FloPatch delivers immediate, clear data to aid in clinical decision-making processes, thereby advancing the effectiveness of patient care through precision fluid management.